The combined technologies will be available for use by customers using the TrialMaster, First in Functionality, electronic data capture (EDC) solution. The collaboration will allow customers that are conducting clinical research in Phase I to take advantage of a clinical study management and fully mobile electronic data capture system to capture data directly from the patient’s bedside.
For those clients running Phase I-IV clinical studies, the combination will unify the capture, reporting, exporting and archival of clinical data into a common web-based, user-interface. The final warehouse for data may reside in SQL, Oracle Clinical database tables or in SAS.
Stephen Johnson, COO of OmniComm, said: “The integration of OmniComm’s TrialMaster and Logos Technologies Alphadas extends the capabilities for data collected from Alphadas to be combined with clinical data imported from other outside sources. It also offers our clients running Phase I-IV clinical studies a common, cost-effective, web-based, interface to use across their enterprise.”